These results suggest that FPB can improve hepatitis by regulating TLR-4/MyD88/NF-κB signaling pathway caused by hyperglycemia in HFD-induced NAFLD mice. The gene discussed is TLR4; the disease is metabolic dysfunction-associated steatotic liver disease.